Table 1.
Variable | Value | |
---|---|---|
Number of patients | 71 | |
Sex (M : F) | 28 : 43 | |
Age, years (±SD) | 58 ± 13 | |
Organ of origin | ||
(i) Gastric | 26 (36.6%) | |
(ii) Colorectal | 17 (23.9%) | |
(iii) Hepatobiliary-pancreatic | 9 (12.7%) | |
(iv) Ovarian | 6 (8.5%) | |
(v) Appendiceal | 5 (7.0%) | |
(vi) PMP | 4 (5.6%) | |
(vii) CUP, mesothelioma, yolk sac, prostate | 3 (4.2%) | |
Extraperitoneal metastasis | ||
(i) Malignant pleural effusion | 3 (4.2%) | |
(ii) Others | 0 | |
Peritoneal Cancer Index (PCI), mean ± SD | 19.3 ± 12.5 | |
Karnofsky Index before first PIPAC, mean ± SD | 80.3 ± 14.7 | |
Previous surgery | ||
(i) CRS and HIPEC | 10 (14.1%) | |
(ii) Gastrectomy | 11 (15.5%) | |
(iii) Colectomy | 11 (15.5%) | |
(iv) Hysterectomy and adnexectomy | 5 (7.0%) | |
(v) Laparotomy | 9 (12.7%) | |
(vi) Laparoscopy | 4 (5.6%) | |
(vii) Other surgeries | 14 (19.7%) | |
(viii) None | 7 (9.9%) | |
Previous systemic chemotherapy | ||
(i) None | 11 (15.5%) | |
(ii) 1 line | 18 (25.4%) | |
(iii) 2 lines | 17 (23.9%) | |
(iv) 3 lines | 10 (14.1%) | |
(v) >3 lines | 15 (21.1%) | |
Simultaneous chemotherapy | 42 (59.1%) |